Rapid Diagnostics Test Readers Market

Rapid Diagnostics Test Readers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Global Rapid Diagnostics Test Readers Market: Introduction

Rapid diagnostic test readers are laboratory diagnostics tools used for the diagnosis and analysis of various diseases in healthcare facilities. These are used with various immunoassays and biochemical tests. Rapid diagnostic test readers offer several advantages over the conventional ones, such as quick test results, easy-to-conduct diagnostics tests, save time, precise detection, and less complications. Thus, rapid diagnostics readers are an emerging tool for diagnosis of various disease indications in limited resource settings and remote locations where conventional approaches are inadequate or not available.

Key Drivers of Global Rapid Diagnostics Test Readers Market

Increase in Incidence of Infections

Emerging and re-emerging infectious diseases are deemed to be a public health threat worldwide. A need for constant awareness and readiness and preparedness to deal with infectious disease outbreaks has been observed, which may cause a dangerous threat to the public. According to the BioMed Central Ltd (part of Springer Nature), the Centers for Diseases Control and Prevention defined syndromic surveillance (SS) as surveillance using health-related data that precedes diagnosis and signals a sufficient probability of a case or an outbreak to warrant further public health response. Furthermore, high prevalence of infectious diseases, such as hepatitis, tuberculosis, retroviral infections, and endocrine disorders, viz., diabetes, thyroid disorders, etc., is likely to drive the demand for rapid diagnostics test readers during the forecast period. According to the World Health Organization, in 2016, more than 71 million people were affected with hepatitis C infection globally. Furthermore, according to the HIV.gov website, around 36.7 million people were living with HIV/AIDS worldwide by the end of 2016. Thus, high prevalence and rise in incidence rate of infectious diseases across the globe is a key factor driving the rapid diagnostics test readers market at a rapid pace.

Increase in Incidence Rate of Influenza

Influenza is a respiratory infection caused by influenza viruses and spreads easily. Influenza viruses undergo constant genetic change, which has substantial impact on induced immunity and considerations for vaccine composition. According to the World Health Organization (WHO), when an infected person coughs or sneezes, droplets containing viruses (infectious droplets) are dispersed into the air and can spread up to one meter, and infect persons in close proximity who breathe these droplets in. People should cover their mouth and nose with a tissue while coughing and wash their hands regularly in order to prevent transmission. Hence, increase in incidence rate of influenza drives the global rapid diagnostics test readers market.

North America to Account for Major Share of Global Rapid Diagnostics Test Readers Market

North America is projected to account for a major share of the global rapid diagnostics test readers market during the forecast period. North America is projected to hold a leading share of the global market owing to easy availability of rapid diagnostics test readers, early adoption of technologically advanced products, and a rise in the demand for point-of-care testing devices among healthcare institutions in the region. Following North America, Europe is projected to account for a prominent share of the global rapid diagnostics test readers market during the forecast period. Well-established healthcare facilities, emerging trend of preventive diagnostics, and increase in geriatric population in the region are estimated to drive the market in Europe. The rapid diagnostics test readers market in Asia Pacific is projected to expand at a significant CAGR during the forecast period owing to rapidly changing healthcare infrastructure in emerging countries such as China and India, increase in per capita healthcare expenditure, and high incidence and prevalence rates of infectious diseases in the region.

Key Players Operating in Global Rapid Diagnostics Test Readers Market

The global rapid diagnostics test readers market is highly consolidated owing to the presence of several key players. Leading players operating in the global rapid diagnostics test readers market include:

  • Abbott laboratories
  • Danaher Corporation
  • Detekt Biomedical LLC
  • QIAGEN
  • Becton, Dickinson and Company
  • DCN Diagnostics
  • Erba Mannheim
  • Thermo Fisher Scientific Inc
  • Reagena Oy Ltd
  • Chembio Diagnostic Systems
  • Now Diagnostic
  • Shanghai Chemtron Biotech
  • Nanjing Norman Biological Technology
  • Atals Medical

Global Rapid Diagnostics Test Readers Market: Research Scope

Global Rapid Diagnostics Test Readers Market, by Type

  • Handheld Rapid Diagnostic Readers
  • Desktop Rapid Diagnostic Readers

Global Rapid Diagnostics Test Readers Market, by Technology

  • Enzyme-linked immunosorbent assay detection technology (ELISA)
  • Chemiluminescent immunoassay technology (CLIA)
  • Fluorescent immunoassay detection technology (FIA)
  • Others

Global Rapid Diagnostics Test Readers Market, by Application

  • Infectious Diseases
  • Endocrinology
  • Hematology
  • Fertility Testing
  • Drugs of Abuse
  • Others

Global Rapid Diagnostics Test Readers Market, by End-user

  • Hospitals
  • Ambulatory surgery centers
  • Diagnostics laboratories
  • Academic and research institutes
  • Others

Global Rapid Diagnostics Test Readers Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

N/A

Copyright © Transparency Market Research, Inc. All Rights reserved